168 related articles for article (PubMed ID: 19026501)
1. Microinvasive ductal carcinoma in situ: clinical presentation, imaging features, pathologic findings, and outcome.
Vieira CC; Mercado CL; Cangiarella JF; Moy L; Toth HK; Guth AA
Eur J Radiol; 2010 Jan; 73(1):102-7. PubMed ID: 19026501
[TBL] [Abstract][Full Text] [Related]
2. Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation.
Parikh RR; Haffty BG; Lannin D; Moran MS
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):7-13. PubMed ID: 20950955
[TBL] [Abstract][Full Text] [Related]
3. Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis.
Zhang G; Li C; Tian G; Cheng X; Li Y; Ma L
Medicine (Baltimore); 2020 Dec; 99(52):e23593. PubMed ID: 33350734
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with ductal carcinoma in situ and sentinel node biopsy.
Meretoja TJ; Heikkilä PS; Salmenkivi K; Leidenius MH
Ann Surg Oncol; 2012 Jul; 19(7):2345-51. PubMed ID: 22395995
[TBL] [Abstract][Full Text] [Related]
5. Lesion size is a major determinant of the mammographic features of ductal carcinoma in situ: findings from the Sloane project.
Evans A; Clements K; Maxwell A; Bishop H; Hanby A; Lawrence G; Pinder SE;
Clin Radiol; 2010 Mar; 65(3):181-4. PubMed ID: 20152272
[TBL] [Abstract][Full Text] [Related]
6. The clinical features and management of women with ductal carcinoma in situ with microinvasion: A retrospective Cohort study.
Li Y; Zhang S; Wei X; Zhang J
Int J Surg; 2015 Jul; 19():91-4. PubMed ID: 26013173
[TBL] [Abstract][Full Text] [Related]
7. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast.
van la Parra RF; Ernst MF; Barneveld PC; Broekman JM; Rutten MJ; Bosscha K
Eur J Surg Oncol; 2008 Jun; 34(6):631-5. PubMed ID: 17851019
[TBL] [Abstract][Full Text] [Related]
8. Clinical and imaging characteristics of breast ductal carcinoma in situ with microinvasion.
Han S; Qiu F; Han Y; Xu Y; Yin J; Xing F; Bian X; He G
J Appl Clin Med Phys; 2021 Jan; 22(1):293-298. PubMed ID: 33332730
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy for ductal carcinoma in situ: an evolving approach at the University of Florida.
Camp R; Feezor R; Kasraeian A; Cendan J; Schell S; Wilkinson E; Copeland E; Lind S
Breast J; 2005; 11(6):394-7. PubMed ID: 16297082
[TBL] [Abstract][Full Text] [Related]
10. Palpable ductal carcinoma in situ: analysis of radiological and histological features of a large series with 5-year follow-up.
Sundara Rajan S; Verma R; Shaaban AM; Sharma N; Dall B; Lansdown M
Clin Breast Cancer; 2013 Dec; 13(6):486-91. PubMed ID: 24267733
[TBL] [Abstract][Full Text] [Related]
11. Local tumor recurrence following breast-conservation therapy: correlation of histopathologic findings with detection method and mammographic findings.
Giess CS; Keating DM; Osborne MP; Rosenblatt R
Radiology; 1999 Sep; 212(3):829-35. PubMed ID: 10478253
[TBL] [Abstract][Full Text] [Related]
12. Image-guided core breast biopsy of ductal carcinoma in situ presenting as a non-calcified abnormality.
DiPiro PJ; Meyer JE; Denison CM; Frenna TH; Harvey SC; Smith DN
Eur J Radiol; 1999 Jun; 30(3):231-6. PubMed ID: 10452723
[TBL] [Abstract][Full Text] [Related]
13. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade.
Jansen SA; Newstead GM; Abe H; Shimauchi A; Schmidt RA; Karczmar GS
Radiology; 2007 Dec; 245(3):684-91. PubMed ID: 18024450
[TBL] [Abstract][Full Text] [Related]
14. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
15. Microinvasive breast carcinoma carries an excellent prognosis regardless of the tumor characteristics.
Shatat L; Gloyeske N; Madan R; O'Neil M; Tawfik O; Fan F
Hum Pathol; 2013 Dec; 44(12):2684-9. PubMed ID: 24071019
[TBL] [Abstract][Full Text] [Related]
16. Casting-type calcifications with invasion and high-grade ductal carcinoma in situ: a more aggressive disease?
Zunzunegui RG; Chung MA; Oruwari J; Golding D; Marchant DJ; Cady B
Arch Surg; 2003 May; 138(5):537-40. PubMed ID: 12742959
[TBL] [Abstract][Full Text] [Related]
17. The role of sonography in patients with breast cancer presenting as an axillary mass.
Park SY; Kim EK; Oh KK; Lee KS; Park BW
Korean J Radiol; 2002; 3(3):189-93. PubMed ID: 12271164
[TBL] [Abstract][Full Text] [Related]
18. Breast ductal carcinoma in situ with micro-invasion versus ductal carcinoma in situ: a comparative analysis of clinicopathological and mammographic findings.
Zhang M; Lin Q; Su XH; Cui CX; Bian TT; Wang CQ; Zhao J; Li LL; Ma JZ; Huang JL
Clin Radiol; 2021 Oct; 76(10):787.e1-787.e7. PubMed ID: 34052010
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of intraductal carcinoma of the breast.
Patchefsky AS; Schwartz GF; Finkelstein SD; Prestipino A; Sohn SE; Singer JS; Feig SA
Cancer; 1989 Feb; 63(4):731-41. PubMed ID: 2536585
[TBL] [Abstract][Full Text] [Related]
20. Mammographically non-calcified ductal carcinoma in situ: sonographic features with pathological correlation in 35 patients.
Mesurolle B; El-Khoury M; Khetani K; Abdullah N; Joseph L; Kao E
Clin Radiol; 2009 Jun; 64(6):628-36. PubMed ID: 19414087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
